Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urothelial Carcinoma of the Bladder × Doxorubicin × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 10 Burkitt Lymphoma 9 Neoplasms 8 Lymphoma, Follicular 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell, Marginal Zone 3 Liposarcoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Hodgkin Disease 3 Endometrial Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Osteosarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Thymoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡